About Eliksa

Eliksa Therapeutics was founded in 2021 to deliver on the mission of harnessing the regenerative properties of amniotic fluid and amniotic membrane to heal human disease.

OUR PEOPLE

Leadership Team

Armen.jfif

Armen Karamanian, MD, PhD

Co-Founder & CEO

John.jfif

John Phillips, MD

Advisor

Jane.jfif

Jane Hollingsworth

Co-Founder & Executive Chairman

Christy.jfif

Christy Kaupinen

Advisor

Garrett.jfif

Garrett Vygantas, MD

Advisor

Eliksa Scientists

NEWS

Eliksa In The Press

Coming soon